Turner Scientific's preclinical contract research services help advance our clients' compounds and devices toward IND/IDE approval and clinical trials by evaluating efficacy, and detecting and defining ototoxicity.
We serve a wide variety of biotechnology companies, pharmaceutical sponsors, and general contract research organization (CRO) clients by assessing the efficacy of new hearing/tinnitus treatments, and the potential for ototoxicity, hearing loss, tinnitus, and balance/vestibular disorders of any medication.
As a niche expert partner, Turner Scientific provides unmatched study design and execution, data analysis, specialty report writing, and sponsor communication by hearing research experts.
Turner Scientific's sponsors benefit from advantages that no other otic research group can offer.
Our exclusive focus on hearing and vestibular function allows unparalleled expertise in audiologic function and testing.
As a small business, we provide flexibility and can rapidly adjust to study developments and the changing needs of our sponsors.
We conduct studies of any size - from focused non-GLP pilot research to large-scale GLP toxicity and efficacy studies.
We have partnered with a network of world-renowned auditory scientists to provide expert consultation as needed.
Our new research space features state-of-the-art equipment and capabilities.
Turner Scientific offers a full range of otic preclinical research capabilities: